English

AKESIS PHARMACEUTICALS, INC.

EDGAR

Quarterly report (10-Q) · filed 2008-11-05

42 filing records in this dataset, filed from 2000-04-03 to 2008-11-05. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2008-09-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-1.17 million USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -3014291 USD Source
Operating Cash Flow: -1843050 USD Source

Cash and cash equivalents: 780 thousand USD 2008-09-30 Source
Exact value

779616 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-11-05.

Financial data available through: 2006-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2004-12-31
Operating income: 7 of 11 periods available· newest 2004-12-31
Net income: 9 of 11 periods available· newest 2006-12-31
Operating cash flow: 9 of 11 periods available· newest 2006-12-31
Capital expenditure: 8 of 11 periods available· newest 2005-12-31
Total assets: 5 of 11 periods available· newest 2006-12-31
Total liabilities: 4 of 11 periods available· newest 2006-12-31
Current assets: 8 of 11 periods available· newest 2006-12-31
Current liabilities: 8 of 11 periods available· newest 2006-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2006-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 1.75 million

Prior period

−USD 3.11 million

2005-01-01 – 2005-12-31
Current period

−USD 1.36 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

-1357992 − -3105826 = 1747834 USD

-3105826 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
-1357992 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AKESIS PHARMACEUTICALS, INC. · 2006-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Year-over-year change in Net income: 1747834 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1357992 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3724 Input fundies:NetIncome: -3105826 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3724
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 286,383

Prior period

−USD 1.16 million

2005-01-01 – 2005-12-31
Current period

−USD 877,807

2006-01-01 – 2006-12-31

Exact inputs and evidence

-877807 − -1164190 = 286383 USD

-1164190 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
-877807 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AKESIS PHARMACEUTICALS, INC. · 2006-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Year-over-year change in Operating cash flow: 286383 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -877807 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3892 Input fundies:OperatingCashFlow: -1164190 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3892
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2004 2004-01-01 – 2004-12-31

Revenue USD 0
Cost of revenue USD 0
Operating expenses USD 1.52 million
Other operating costs Derived USD 0
Operating income −USD 1.52 million
Tax, interest and other Derived USD 7,848
Net income −USD 1.53 million

Cash

Operating cash flow −USD 501,224
Capital expenditure USD 0
Free cash flow Derived −USD 501,224

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 Operating loss: operating costs were 240% of revenue.
1999 Operating loss: operating costs were 200% of revenue.
2000 Operating loss: operating costs were 913% of revenue.
2001 Operating loss: operating costs were 1,376% of revenue.
2002 Operating loss: operating costs were 591% of revenue.
2003 Operating loss: operating costs were 631% of revenue.
2004 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1998-01-01 – 1998-12-31	172549	414432 Derived	-241883	1478642 Derived	-1720525	-763984 Derived	Source 1998-01-01 – 1998-12-31: 172549 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -241883 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -1720525 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -700921 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 63063 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	930474	1860068 Derived	-929594	-325382 Derived	-604212	-727514 Derived	Source 1999-01-01 – 1999-12-31: 930474 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -929594 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -604212 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -675786 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 51728 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	33184	302962 Derived	-269778	538865 Derived	-808643	-451332 Derived	Source 2000-01-01 – 2000-12-31: 33184 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -269778 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -808643 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -258854 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 192478 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	35000	481558 Derived	-446558	-67245 Derived	-379313	-857993 Derived	Source 2001-01-01 – 2001-12-31: 35000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -446558 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -379313 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -834349 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 23644 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	26621	157347 Derived	-130726	1961 Derived	-132687	-97857 Derived	Source 2002-01-01 – 2002-12-31: 26621 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -130726 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -132687 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -97857 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 0 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	4785	30182 Derived	-25397	5894 Derived	-31291	-23962 Derived	Source 2003-01-01 – 2003-12-31: 4785 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -25397 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -31291 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -23962 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 0 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	0	1517691 Derived	-1517691	7848 Derived	-1525539	-501224 Derived	Source 2004-01-01 – 2004-12-31: 0 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -1517691 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -1525539 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -501224 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2004

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Revenue	172549	Revenue: 172549 Open source
19991999-12-31	Revenue	930474	Revenue: 930474 Open source
20002000-12-31	Revenue	33184	Revenue: 33184 Open source
20012001-12-31	Revenue	35000	Revenue: 35000 Open source
20022002-12-31	Revenue	26621	Revenue: 26621 Open source
20032003-12-31	Revenue	4785	Revenue: 4785 Open source
20042004-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2004

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Year over year	No prior comparable period	Revenue: 172549 Open source
19991999-12-31	Year over year	439.3%	Revenue: 930474 Open source Revenue: 172549 Open source
20002000-12-31	Year over year	-96.4%	Revenue: 33184 Open source Revenue: 930474 Open source
20012001-12-31	Year over year	5.5%	Revenue: 35000 Open source Revenue: 33184 Open source
20022002-12-31	Year over year	-23.9%	Revenue: 26621 Open source Revenue: 35000 Open source
20032003-12-31	Year over year	-82%	Revenue: 4785 Open source Revenue: 26621 Open source
20042004-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 4785 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -530.8% 2003

Net margin -653.9% 2003

Free cash flow margin -500.8% 2003

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Operating margin	-140.2%	Operating Income: -241883 Open source Revenue: 172549 Open source
19991999-12-31	Operating margin	-99.9%	Operating Income: -929594 Open source Revenue: 930474 Open source
20002000-12-31	Operating margin	-813%	Operating Income: -269778 Open source Revenue: 33184 Open source
20012001-12-31	Operating margin	-1,275.9%	Operating Income: -446558 Open source Revenue: 35000 Open source
20022002-12-31	Operating margin	-491.1%	Operating Income: -130726 Open source Revenue: 26621 Open source
20032003-12-31	Operating margin	-530.8%	Operating Income: -25397 Open source Revenue: 4785 Open source
20042004-12-31	Operating margin	Not reported	Operating Income: -1517691 Open source Revenue: 0 Open source
19981998-12-31	Net margin	-997.1%	Net Income: -1720525 Open source Revenue: 172549 Open source
19991999-12-31	Net margin	-64.9%	Net Income: -604212 Open source Revenue: 930474 Open source
20002000-12-31	Net margin	-2,436.8%	Net Income: -808643 Open source Revenue: 33184 Open source
20012001-12-31	Net margin	-1,083.8%	Net Income: -379313 Open source Revenue: 35000 Open source
20022002-12-31	Net margin	-498.4%	Net Income: -132687 Open source Revenue: 26621 Open source
20032003-12-31	Net margin	-653.9%	Net Income: -31291 Open source Revenue: 4785 Open source
20042004-12-31	Net margin	Not reported	Net Income: -1525539 Open source Revenue: 0 Open source
19981998-12-31	Free cash flow margin	-442.8%	Revenue: 172549 Open source Operating Cash Flow: -700921 Open source Capital Expenditure: 63063 Open source
19991999-12-31	Free cash flow margin	-78.2%	Revenue: 930474 Open source Operating Cash Flow: -675786 Open source Capital Expenditure: 51728 Open source
20002000-12-31	Free cash flow margin	-1,360.1%	Revenue: 33184 Open source Operating Cash Flow: -258854 Open source Capital Expenditure: 192478 Open source
20012001-12-31	Free cash flow margin	-2,451.4%	Revenue: 35000 Open source Operating Cash Flow: -834349 Open source Capital Expenditure: 23644 Open source
20022002-12-31	Free cash flow margin	-367.6%	Revenue: 26621 Open source Operating Cash Flow: -97857 Open source Capital Expenditure: 0 Open source
20032003-12-31	Free cash flow margin	-500.8%	Revenue: 4785 Open source Operating Cash Flow: -23962 Open source Capital Expenditure: 0 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -501224 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -501.2K 2004

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Operating cash flow	-700921	Operating Cash Flow: -700921 Open source
19991999-12-31	Operating cash flow	-675786	Operating Cash Flow: -675786 Open source
20002000-12-31	Operating cash flow	-258854	Operating Cash Flow: -258854 Open source
20012001-12-31	Operating cash flow	-834349	Operating Cash Flow: -834349 Open source
20022002-12-31	Operating cash flow	-97857	Operating Cash Flow: -97857 Open source
20032003-12-31	Operating cash flow	-23962	Operating Cash Flow: -23962 Open source
20042004-12-31	Operating cash flow	-501224	Operating Cash Flow: -501224 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -501.2K 2004

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Free cash flow	-763984	Operating Cash Flow: -700921 Open source Capital Expenditure: 63063 Open source
19991999-12-31	Free cash flow	-727514	Operating Cash Flow: -675786 Open source Capital Expenditure: 51728 Open source
20002000-12-31	Free cash flow	-451332	Operating Cash Flow: -258854 Open source Capital Expenditure: 192478 Open source
20012001-12-31	Free cash flow	-857993	Operating Cash Flow: -834349 Open source Capital Expenditure: 23644 Open source
20022002-12-31	Free cash flow	-97857	Operating Cash Flow: -97857 Open source Capital Expenditure: 0 Open source
20032003-12-31	Free cash flow	-23962	Operating Cash Flow: -23962 Open source Capital Expenditure: 0 Open source
20042004-12-31	Free cash flow	-501224	Operating Cash Flow: -501224 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

6.1% 2004

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Liabilities / assets	Not reported	No source recorded
1999-12-31	Liabilities / assets	Not reported	No source recorded
2000-12-31	Liabilities / assets	Not reported	No source recorded
2001-12-31	Liabilities / assets	Not reported	No source recorded
2002-12-31	Liabilities / assets	Not reported	Total Assets: 20 Open source
20032003-12-31	Liabilities / assets	Not reported	Total Liabilities: 122551 Open source Total Assets: 0 Open source
20042004-12-31	Liabilities / assets	6.1%	Total Liabilities: 82436 Open source Total Assets: 1350250 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

16.38× 2004

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Current assets / current liabilities	Not reported	No source recorded
19991999-12-31	Current assets / current liabilities	0.6×	Current Assets: 1379281 Open source Current Liabilities: 2282636 Open source
20002000-12-31	Current assets / current liabilities	0.3×	Current Assets: 490139 Open source Current Liabilities: 1653699 Open source
20012001-12-31	Current assets / current liabilities	0.37×	Current Assets: 511224 Open source Current Liabilities: 1388554 Open source
20022002-12-31	Current assets / current liabilities	0×	Current Assets: 20 Open source Current Liabilities: 708487 Open source
20032003-12-31	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 29621 Open source
20042004-12-31	Current assets / current liabilities	16.38×	Current Assets: 1350250 Open source Current Liabilities: 82436 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1998-01-01 – 1998-12-31	−USD 1.72 million Exact value Exact value: -1720525 USD 1998-01-01 – 1998-12-31: -1720525 USD Inspect Net Income Open source Share or cite Citation for Net Income · AKESIS PHARMACEUTICALS, INC. · 1998-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Net Income: -1720525 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1720525 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0000788738-00-000044.txt#1604 The citation records this snapshot. The page link may show a newer release later.	−USD 700,921 Exact value Exact value: -700921 USD 1998-01-01 – 1998-12-31: -700921 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AKESIS PHARMACEUTICALS, INC. · 1998-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Operating Cash Flow: -700921 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -700921 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0000788738-00-000044.txt#1627 The citation records this snapshot. The page link may show a newer release later.	USD 63,063 Exact value Exact value: 63063 USD 1998-01-01 – 1998-12-31: 63063 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AKESIS PHARMACEUTICALS, INC. · 1998-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Capital Expenditure: 63063 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 63063 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0000788738-00-000044.txt#1631 The citation records this snapshot. The page link may show a newer release later.	−USD 763,984 Calculation and evidence -700921 − 63063 USD Exact free cash flow: -763984 USD 1998-01-01 – 1998-12-31: -700921 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 63063 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AKESIS PHARMACEUTICALS, INC. · 1998-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Free cash flow: -763984 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -700921 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0000788738-00-000044.txt#1627 Input fundies:CapitalExpenditure: 63063 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0000788738-00-000044.txt#1631 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 604,212 Exact value Exact value: -604212 USD 1999-01-01 – 1999-12-31: -604212 USD Inspect Net Income Open source Share or cite Citation for Net Income · AKESIS PHARMACEUTICALS, INC. · 1999-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Net Income: -604212 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -604212 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001013176-01-500012.txt#1670 The citation records this snapshot. The page link may show a newer release later.	−USD 675,786 Exact value Exact value: -675786 USD 1999-01-01 – 1999-12-31: -675786 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AKESIS PHARMACEUTICALS, INC. · 1999-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Operating Cash Flow: -675786 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -675786 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001013176-01-500012.txt#1694 The citation records this snapshot. The page link may show a newer release later.	USD 51,728 Exact value Exact value: 51728 USD 1999-01-01 – 1999-12-31: 51728 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AKESIS PHARMACEUTICALS, INC. · 1999-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Capital Expenditure: 51728 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 51728 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001013176-01-500012.txt#1697 The citation records this snapshot. The page link may show a newer release later.	−USD 727,514 Calculation and evidence -675786 − 51728 USD Exact free cash flow: -727514 USD 1999-01-01 – 1999-12-31: -675786 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 51728 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AKESIS PHARMACEUTICALS, INC. · 1999-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Free cash flow: -727514 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -675786 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001013176-01-500012.txt#1694 Input fundies:CapitalExpenditure: 51728 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001013176-01-500012.txt#1697 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 808,643 Exact value Exact value: -808643 USD 2000-01-01 – 2000-12-31: -808643 USD Inspect Net Income Open source Share or cite Citation for Net Income · AKESIS PHARMACEUTICALS, INC. · 2000-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Net Income: -808643 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -808643 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001078782-02-000167.txt#1493 The citation records this snapshot. The page link may show a newer release later.	−USD 258,854 Exact value Exact value: -258854 USD 2000-01-01 – 2000-12-31: -258854 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AKESIS PHARMACEUTICALS, INC. · 2000-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Operating Cash Flow: -258854 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -258854 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001078782-02-000167.txt#1551 The citation records this snapshot. The page link may show a newer release later.	USD 192,478 Exact value Exact value: 192478 USD 2000-01-01 – 2000-12-31: 192478 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AKESIS PHARMACEUTICALS, INC. · 2000-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Capital Expenditure: 192478 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 192478 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001078782-02-000167.txt#1560 The citation records this snapshot. The page link may show a newer release later.	−USD 451,332 Calculation and evidence -258854 − 192478 USD Exact free cash flow: -451332 USD 2000-01-01 – 2000-12-31: -258854 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 192478 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AKESIS PHARMACEUTICALS, INC. · 2000-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Free cash flow: -451332 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -258854 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001078782-02-000167.txt#1551 Input fundies:CapitalExpenditure: 192478 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001078782-02-000167.txt#1560 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 379,313 Exact value Exact value: -379313 USD 2001-01-01 – 2001-12-31: -379313 USD Inspect Net Income Open source Share or cite Citation for Net Income · AKESIS PHARMACEUTICALS, INC. · 2001-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Net Income: -379313 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -379313 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001023175-03-000070.txt#1161 The citation records this snapshot. The page link may show a newer release later.	−USD 834,349 Exact value Exact value: -834349 USD 2001-01-01 – 2001-12-31: -834349 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AKESIS PHARMACEUTICALS, INC. · 2001-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Operating Cash Flow: -834349 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -834349 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001023175-03-000070.txt#1181 The citation records this snapshot. The page link may show a newer release later.	USD 23,644 Exact value Exact value: 23644 USD 2001-01-01 – 2001-12-31: 23644 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AKESIS PHARMACEUTICALS, INC. · 2001-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Capital Expenditure: 23644 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23644 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001023175-03-000070.txt#1184 The citation records this snapshot. The page link may show a newer release later.	−USD 857,993 Calculation and evidence -834349 − 23644 USD Exact free cash flow: -857993 USD 2001-01-01 – 2001-12-31: -834349 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 23644 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AKESIS PHARMACEUTICALS, INC. · 2001-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Free cash flow: -857993 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -834349 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001023175-03-000070.txt#1181 Input fundies:CapitalExpenditure: 23644 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001023175-03-000070.txt#1184 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 132,687 Exact value Exact value: -132687 USD 2002-01-01 – 2002-12-31: -132687 USD Inspect Net Income Open source Share or cite Citation for Net Income · AKESIS PHARMACEUTICALS, INC. · 2002-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Net Income: -132687 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -132687 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-05-088811.txt#5055 The citation records this snapshot. The page link may show a newer release later.	−USD 97,857 Exact value Exact value: -97857 USD 2002-01-01 – 2002-12-31: -97857 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AKESIS PHARMACEUTICALS, INC. · 2002-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Operating Cash Flow: -97857 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -97857 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-05-088811.txt#5223 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2002-01-01 – 2002-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AKESIS PHARMACEUTICALS, INC. · 2002-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-05-088811.txt#5277 The citation records this snapshot. The page link may show a newer release later.	−USD 97,857 Calculation and evidence -97857 − 0 USD Exact free cash flow: -97857 USD 2002-01-01 – 2002-12-31: -97857 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AKESIS PHARMACEUTICALS, INC. · 2002-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Free cash flow: -97857 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -97857 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-05-088811.txt#5223 Input fundies:CapitalExpenditure: 0 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-05-088811.txt#5277 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 31,291 Exact value Exact value: -31291 USD 2003-01-01 – 2003-12-31: -31291 USD Inspect Net Income Open source Share or cite Citation for Net Income · AKESIS PHARMACEUTICALS, INC. · 2003-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Net Income: -31291 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31291 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-06-092577.txt#5462 The citation records this snapshot. The page link may show a newer release later.	−USD 23,962 Exact value Exact value: -23962 USD 2003-01-01 – 2003-12-31: -23962 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AKESIS PHARMACEUTICALS, INC. · 2003-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Operating Cash Flow: -23962 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23962 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-06-092577.txt#5642 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2003-01-01 – 2003-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AKESIS PHARMACEUTICALS, INC. · 2003-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-06-092577.txt#5696 The citation records this snapshot. The page link may show a newer release later.	−USD 23,962 Calculation and evidence -23962 − 0 USD Exact free cash flow: -23962 USD 2003-01-01 – 2003-12-31: -23962 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AKESIS PHARMACEUTICALS, INC. · 2003-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Free cash flow: -23962 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23962 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-06-092577.txt#5642 Input fundies:CapitalExpenditure: 0 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-06-092577.txt#5696 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 1.53 million Exact value Exact value: -1525539 USD 2004-01-01 – 2004-12-31: -1525539 USD Inspect Net Income Open source Share or cite Citation for Net Income · AKESIS PHARMACEUTICALS, INC. · 2004-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Net Income: -1525539 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1525539 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3724 The citation records this snapshot. The page link may show a newer release later.	−USD 501,224 Exact value Exact value: -501224 USD 2004-01-01 – 2004-12-31: -501224 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AKESIS PHARMACEUTICALS, INC. · 2004-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Operating Cash Flow: -501224 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -501224 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3892 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2004-01-01 – 2004-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AKESIS PHARMACEUTICALS, INC. · 2004-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-06-092577.txt#5696 The citation records this snapshot. The page link may show a newer release later.	−USD 501,224 Calculation and evidence -501224 − 0 USD Exact free cash flow: -501224 USD 2004-01-01 – 2004-12-31: -501224 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AKESIS PHARMACEUTICALS, INC. · 2004-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Free cash flow: -501224 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -501224 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3892 Input fundies:CapitalExpenditure: 0 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-06-092577.txt#5696 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 3.11 million Exact value Exact value: -3105826 USD 2005-01-01 – 2005-12-31: -3105826 USD Inspect Net Income Open source Share or cite Citation for Net Income · AKESIS PHARMACEUTICALS, INC. · 2005-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Net Income: -3105826 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3105826 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3724 The citation records this snapshot. The page link may show a newer release later.	−USD 1.16 million Exact value Exact value: -1164190 USD 2005-01-01 – 2005-12-31: -1164190 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AKESIS PHARMACEUTICALS, INC. · 2005-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Operating Cash Flow: -1164190 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1164190 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3892 The citation records this snapshot. The page link may show a newer release later.	USD 21,584 Exact value Exact value: 21584 USD 2005-01-01 – 2005-12-31: 21584 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AKESIS PHARMACEUTICALS, INC. · 2005-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Capital Expenditure: 21584 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21584 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-06-092577.txt#5696 The citation records this snapshot. The page link may show a newer release later.	−USD 1.19 million Calculation and evidence -1164190 − 21584 USD Exact free cash flow: -1185774 USD 2005-01-01 – 2005-12-31: -1164190 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 21584 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AKESIS PHARMACEUTICALS, INC. · 2005-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Free cash flow: -1185774 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1164190 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3892 Input fundies:CapitalExpenditure: 21584 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-06-092577.txt#5696 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 1.36 million Exact value Exact value: -1357992 USD 2006-01-01 – 2006-12-31: -1357992 USD Inspect Net Income Open source Share or cite Citation for Net Income · AKESIS PHARMACEUTICALS, INC. · 2006-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Net Income: -1357992 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1357992 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3724 The citation records this snapshot. The page link may show a newer release later.	−USD 877,807 Exact value Exact value: -877807 USD 2006-01-01 – 2006-12-31: -877807 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AKESIS PHARMACEUTICALS, INC. · 2006-12-31 AKESIS PHARMACEUTICALS, INC. (edgar:1042420) Operating Cash Flow: -877807 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:45:25Z Snapshot: d9cf1bd103c4e94d8266a21fce432ed82617cb6710a58d8cdc60c5a1be19ecfb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1042420/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -877807 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1042420/0001193125-07-119813.txt#3892 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

42 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001042420, 1042420, edgar:1042420

Also known as LIBERTY MINT LTD

AKESIS PHARMACEUTICALS, INC.

Latest quarter

Revenue

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2004 2004-01-01 – 2004-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation